Home / Pharmaceutical / Global ADME Toxicology Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 To 2025

Global ADME Toxicology Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 To 2025

Published: May 2016 | Published By: Acute Market Research

Global ADME Toxicology Testing Market- Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2017 - 2025, the ADME toxicology testing was valued at USD 7,726.7 Mn in 2016, and is expected to reach USD 14391.5 Mn by 2025, expanding at a CAGR of 10.6% from 2017 to 2025.

Market Insights
ADME is the abbreviation for absorption distribution, metabolism and elimination, a pharmacology and pharmacokinetics term that describes the disposition of a drug or compound inside the human body. ADME comprises set of four processes that develop the performance of a drug on human tissue and ADME toxicology testing is applied for the development of a new drug. ADME toxicology facilitated pharmaceutical manufacturing company to minimize their drug discovery time, testing complications, and to reduce the cost of drug development. The growing application of ADME toxicology testing by pharmaceuticals and biotechnology companies is assisting the market growth of the ADME toxicology testing market. One of the key factors responsible for late stage drug failures is the inability of drug candidates to imitate in humans the safety profile witnessed in animal models. Before introduction and acceptance of ADME toxicology testing, drug development process included toxicity and efficacy testing in in-vivo environment which was responsible for late stage failure of drugs in human body due to anatomical and genetic differences between animals and humans. To overcome this barrier of drug failure manufacturers across the globe opted for ADME toxicity testing in early drug developmental phases of pre-clinical trials. Increasing adoption of ADME toxicity testing as cost and time curbing tool is further expected to drive growth of this market. Introduction of technologically advanced computer based testing models are additionally fuelling growth of this market. According to market stakeholders, recently pre-clinical ADME toxicology testing is emerging to take on a new application in the drug-discovery venture capital (VC) industry’s financial decision that corresponds in importance and scope to its established role in the scientific decisions of drug discovery firms.

Market Competition Assessment
The ADME toxicology testing market is observed as the most diversified and competitive market comprising large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are Cellartis AB, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Caliper Life Sciences, Inc., Promega Corporation, Cyprotex PLC, Beckman Coulter, Inc., Optivia Biotechnology, Inc., Accelrys, Inc., Molecular Discovery Ltd., MultiCASE, Inc., Xceleron, Inc., ACEA Biosciences, Inc., Albany Molecular Research, Inc., and CeeTox, Inc.

Key Market Movements
• Rising application of ADME toxicology testing by pharmaceuticals and biotechnology companies
• Growing concerns over application of animals in clinical trials
• Increase in demand of cell-based assays in drug discovery
• Escalating adoption of ADME toxicity testing as cost and time curbing tool

Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 ADME Toxicology Testing Market, by Product Type, 2017 (USD Mn)
2.2 ADME Toxicology Testing Market Share, by Technology Type, 2017 & 2025 (Value %)
2.3 ADME Toxicology Testing Market Share, by Geography, 2017 (Value %)

Chapter 3 Global ADME Toxicology Testing Market: Market Dynamics and Outlook
3.1 ADME Toxicology Testing : Current and Future Trends
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.6 Market Share Analysis: Key ADME Toxicology Testing Manufacturers, 2017 (%)

Chapter 4 Global ADME Toxicology Testing Market, by Product Type
4.1 Preface
4.2 Instruments
4.3 Software Solutions
4.4 Assays systems
4.5 Reagents
4.6 Others

Chapter 5 Global ADME Toxicology Testing Market, by Technology Type
5.1 Preface
5.2 In-vitro Tests
5.2.1 Biochemical Testing
5.2.2 Cell Testing
5.3 In-vivo Tests

Chapter 6 Global ADME Toxicology Testing Market, by Geography
6.1 Preface
6.2 North America
6.2.1 U.S
6.2.2 Canada
6.3 Europe
6.3.1 U.K
6.3.2 Germany
6.3.3 Rest of Europe
6.4 Asia Pacific
6.4.1 China
6.4.2 Japan
6.4.3 Rest of Asia Pacific
6.5 Latin America (LATAM)
6.5.1 Brazil
6.5.2 Mexico
6.5.3 Rest of LATAM
6.6 Middle East and Africa (MEA)

Chapter 7 Future Growth Advocacies

Chapter 8 Company Profiles
8.1 Cellartis AB
8.1.1 Business Description
8.1.2 Financial Health and budget allocation
8.1.3 Product Positions/Portfolio
8.1.4 Key Competitors
8.1.5 News Coverage
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Business Description
8.2.2 Financial Health and Budget Allocation
8.2.3 Product Positions/Portfolio
8.2.4 Key Competitors
8.2.5 News Coverage
8.3 Agilent Technologies, Inc.
8.3.1 Business Description
8.3.2 Financial Health and Budget Allocation
8.3.3 Product Positions/Portfolio
8.3.4 Key Competitors
8.3.5 News Coverage
8.4 Bio-Rad Laboratories, Inc.
8.4.1 Business Description
8.4.2 Financial Health and budget allocation
8.4.3 Product Positions/
8.4.4 Key Competitors
8.4.5 News Coverage
8.5 Caliper Life Sciences, Inc.
8.5.1 Business Description
8.5.2 Financial Health and budget allocation
8.5.3 Product Positions/Portfolio
8.5.4 Key Competitors
8.5.5 News Coverage
8.6 Promega Corporation
8.6.1 Business Description
8.6.2 Financial Health and budget allocation
8.6.3 Product Positions/Portfolio
8.6.4 Key Competitors
8.6.5 News Coverage
8.7 Beckman Coulter, Inc.
8.7.1 Business Description
8.7.2 Financial Health and budget allocation
8.7.3 Product Positions/Portfolio
8.7.4 Key Compsetitors
8.7.5 News Coverage
8.8 Optivia Biotechnology, Inc.
8.8.1 Business Description
8.8.2 Financial Health and budget allocation
8.8.3 Product Positions/Portfolio
8.8.4 Key Competitors
8.8.5 News Coverage
8.9 Cyprotex PLC
8.9.1 Business Description
8.9.2 Financial Health and budget allocation
8.9.3 Product Positions/Portfolio
8.9.4 Key Competitors
8.9.5 News Coverage
8.10 Molecular Discovery Ltd.
8.10.1 Business Description
8.10.2 Financial Health and budget allocation
8.10.3 Product Positions/Portfolio
8.10.4 Key Competitors
8.4.5 News Coverage

TABLE 1 Global ADME Toxicology Testing Market Revenue, by Product Type, 2017 - 2025 (USD Mn)
TABLE 2 Global ADME Toxicology Testing Market Revenue, by Technology Type, 2017 - 2025 (USD Mn)
TABLE 3 Global ADME Toxicology Testing Market Revenue, by Geography, 2017 - 2025 (USD Mn)
TABLE 4 North America ADME Toxicology Testing Market Revenue, by Country, 2017 - 2025 (USD Mn)
TABLE 5 Europe ADME Toxicology Testing Market Revenue, by Country, 2017 - 2025 (USD Mn)
TABLE 6 Asia - Pacific ADME Toxicology Testing Market Revenue, by Country, 2017 - 2025 (USD Mn)
TABLE 7 Latin America ADME Toxicology Testing Market Revenue, by Country, 2017 - 2025 (USD Mn)
TABLE 8 Middle East and Africa ADME Toxicology Testing Market Revenue, by Region, 2017 - 2025 (USD Mn)

FIG. 1 ADME Toxicology Testing : Market Segmentation
FIG. 2 ADME Toxicology Testing Market, by Product Type, 2017 (USD Mn)
FIG. 3 ADME Toxicology Testing Market Share, by Technology Type, 2017 & 2025 (Value %)
FIG. 4 ADME Toxicology Testing Market Share, by Geography, 2017 (Value %)
FIG. 5 Attractive Investment Proposition, ADME Toxicology Testing Market, 2017
FIG. 6 Key Players Market Share Analysis for ADME Toxicology Testing, 2017 (%)
FIG. 7 Global Instruments Market Revenue, 2017 – 2025 (USD Mn)
FIG. 8 Global Software Solutions Market Revenue, 2017 – 2025 (USD Mn)
FIG. 9 Global Assays Systems Market Revenue, 2017– 2025(USD Mn)
FIG. 10 Global Reagents Market Revenue, 2017 – 2025 (USD Mn)
FIG. 11 Global Others Market Revenue, 2017 – 2025 (USD Mn)
FIG. 12 Global In-vitro Tests Market Revenue, 2017 – 2025 (USD Mn)
FIG. 13 Global In-vivo Tests Market Revenue, 2017 – 2025 (USD Mn)
FIG. 14 U.S. ADME Toxicology Testing Market Revenue, 2017 – 2025 (USD Mn)
FIG. 15 Canada ADME Toxicology Testing Market Revenue, 2017 – 2025 (USD Mn)
FIG. 16 U.K. ADME Toxicology Testing Market Revenue, 2017 – 2025 (USD Mn)
FIG. 17 Germany ADME Toxicology Testing Market Revenue, 2017 – 2025 (USD Mn)
FIG. 18 Rest of Europe ADME Toxicology Testing Market Revenue, 2017 – 2025
(USD Mn)
FIG. 19 China ADME Toxicology Testing Market Revenue, 2017 – 2025 (USD Mn)
FIG. 20 Japan ADME Toxicology Testing Market Revenue, 2017 – 2025 (USD Mn)
FIG. 21 Rest of Asia-Pacific ADME Toxicology Testing Market Revenue, 2017 – 2025 (USD
Mn)
FIG. 22 Brazil ADME Toxicology Testing Market Revenue, 2017 – 2025 (USD Mn)
FIG. 23 Mexico ADME Toxicology Testing Market Revenue, 2017 – 2025 (USD Mn)
FIG. 24 Rest of LATAM ADME Toxicology Testing Market Revenue, 2017 – 2025 (USD Mn)

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +